צורה קריסטלית של מעכב בנזילבנזן 2sglt

• 收藏
• 分享

专利权人:

THERACOS SUB LLC;THERACOS INC.

发明人:

申请号：

IL22320512

公开号：

IL223205A

申请日:

2012.11.22

申请国别(地区):

IL

年份:

2020

代理人:

摘要：

Provided are crystalline forms of a compound having an inhibitory effect on sodium-dependent glucose cotransporter SGLT2. The invention also provides pharmaceutical compositions, methods of preparing the crystalline compound, and methods of using the crystalline compound, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT or SGLT2 inhibition.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/